New drug shows potential to reduce ghrelin levels

06 Jan 2020


A new drug undergoing worldwide trials shows potential to reduce ghrelin levels in patients with Prader-Willi syndrome.

Scienmag


Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story